BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17868047)

  • 21. Clinicopathological analysis of T-cell lymphoma in Taiwan according to WHO classification: high incidence of enteropathy-type intestinal T-cell lymphoma.
    Lee MY; Tsou MH; Tan TD; Lu MC
    Eur J Haematol; 2005 Sep; 75(3):221-6. PubMed ID: 16104878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathology review for paediatric non-Hodgkin's lymphoma patients in Japan; a report from the Japan association of childhood leukaemia study (JACLS).
    Nakagawa A; Nakamura S; Nakamine H; Yoshino T; Takimoto T; Horibe K; Ueda K
    Eur J Cancer; 2004 Mar; 40(5):725-33. PubMed ID: 15010074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Non-Hodgkin's lymphomas of the digestive tract and anexal glands in AIDS patients].
    Corti M; Villafañe Fioti MF; Lewi D; Schtirbu R; Narbaitz M; de Dios Soler M
    Acta Gastroenterol Latinoam; 2006 Dec; 36(4):190-6. PubMed ID: 17225446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paediatric lymphoma in China: a clinicopathological study of 213 cases.
    Wang J; Wu X; Shen Y; Xi Z
    Pathology; 2012 Dec; 44(7):622-5. PubMed ID: 23149377
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-anaplastic peripheral T-cell lymphoma in children and adolescents--a retrospective analysis of the NHL-BFM study group.
    Kontny U; Oschlies I; Woessmann W; Burkhardt B; Lisfeld J; Salzburg J; Janda A; Attarbaschi A; Niggli F; Zimmermann M; Reiter A; Klapper W
    Br J Haematol; 2015 Mar; 168(6):835-44. PubMed ID: 25395120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation and management of the "new" lymphoma entities: mantle cell lymphoma, lymphoma of mucosa-associated lymphoid tissue, anaplastic large-cell lymphoma, and primary mediastinal B-cell lymphoma.
    Porcu P; Nichols CR
    Curr Probl Cancer; 1998; 22(5):283-368. PubMed ID: 9869020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austria--a population-based report of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
    Reismüller B; Attarbaschi A; Peters C; Dworzak MN; Pötschger U; Urban C; Fink FM; Meister B; Schmitt K; Dieckmann K; Henze G; Haas OA; Gadner H; Mann G;
    Br J Haematol; 2009 Feb; 144(4):559-70. PubMed ID: 19077160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Retrospective analysis of 54 patients with high risk aggressive T-cell non-Hodgkin lymphomas].
    Yuan XL; Li QC; Zou DH; Zhao YZ; Wang YF; Wang Y; Zhang JW; Qiu LG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):454-7. PubMed ID: 18072627
    [TBL] [Abstract][Full Text] [Related]  

  • 29. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.
    Vose J; Armitage J; Weisenburger D;
    J Clin Oncol; 2008 Sep; 26(25):4124-30. PubMed ID: 18626005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescent non-Hodgkin lymphoma and Hodgkin lymphoma: state of the science.
    Hochberg J; Waxman IM; Kelly KM; Morris E; Cairo MS
    Br J Haematol; 2009 Jan; 144(1):24-40. PubMed ID: 19087093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Société Francaise de Greffe de Moëlle et de Thérapie Cellulaire.
    Le Gouill S; Milpied N; Buzyn A; De Latour RP; Vernant JP; Mohty M; Moles MP; Bouabdallah K; Bulabois CE; Dupuis J; Rio B; Gratecos N; Yakoub-Agha I; Attal M; Tournilhac O; Decaudin D; Bourhis JH; Blaise D; Volteau C; Michallet M;
    J Clin Oncol; 2008 May; 26(14):2264-71. PubMed ID: 18390969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
    Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
    J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytogenetic study on 155 cases of non-Hodgkin' s lymphoma].
    Wang XQ;
    Zhonghua Xue Ye Xue Za Zhi; 2006 Oct; 27(10):656-60. PubMed ID: 17343195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A single-center report on clinical features and treatment response in patients with intestinal T cell non-Hodgkin's lymphomas.
    Novakovic BJ; Novakovic S; Frkovic-Grazio S
    Oncol Rep; 2006 Jul; 16(1):191-5. PubMed ID: 16786145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analysis of extra-nodal NK/T-cell lymphoma and peripheral T-cell lymphoma: significant differences in clinical characteristics and prognosis.
    Lim ST; Hee SW; Quek R; Lim LC; Yap SP; Loong EL; Sng I; Tan LH; Ang MK; Ngeow J; Tham CK; Ngo L; Tan MH; Tao M
    Eur J Haematol; 2008 Jan; 80(1):55-60. PubMed ID: 18028433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pediatric non-Hodgkin lymphoma: a retrospective 14-year experience with Berlin-Frankfurt-Münster (BFM) protocols from a tertiary care hospital in Serbia.
    Dokmanovic L; Krstovski N; Vukanic D; Brasanac D; Rodic P; Cvetkovic M; Janic D
    Pediatr Hematol Oncol; 2012 Mar; 29(2):109-18. PubMed ID: 22376014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapy for non-Hodgkin lymphoma in children with primary immunodeficiency: analysis of 19 patients from the BFM trials.
    Seidemann K; Tiemann M; Henze G; Sauerbrey A; Müller S; Reiter A
    Med Pediatr Oncol; 1999 Dec; 33(6):536-44. PubMed ID: 10573576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Incidence, clinical characteristics and survival of malignant lymphomas: a population-based study from a cancer registry in northern Italy.
    Luminari S; Cesaretti M; Rashid I; Mammi C; Montanini A; Barbolini E; Bellei M; Pennese E; Sirotti MA; Marcheselli L; Partesotti G; Bari A; Maiorana A; Bonacorsi G; Federico M
    Hematol Oncol; 2007 Dec; 25(4):189-97. PubMed ID: 17654762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
    Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
    Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interleukin-10 gene polymorphism influences the prognosis of T-cell non-Hodgkin lymphomas.
    Lee JJ; Kim DH; Lee NY; Sohn SK; Kim JG; Kim HJ; Do YR; Park YH
    Br J Haematol; 2007 May; 137(4):329-36. PubMed ID: 17408400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.